Guidance for Industry on Postmarketing Adverse Event Reporting for Medical Products and Dietary Supplements During an Influenza Pandemic FDA More information...
Petition to Request Exemption from 100 Percent Identity Testing of Dietary Ingredients: Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements FDA More information...
Agency Information Collection Activities; Proposals, Submissions, and Approvals: Premarket Notification for a New Dietary Ingredient FDA More information...
Statement from FDA Commissioner Scott Gottlieb, M.D., on new policy steps for strengthening public warning and notification of recalls FDA More information...
Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA’s new efforts to advance implementation of the new consumer Nutrition Facts label for foods FDA More information...
FDA oversees destruction and recall of kratom products; and reiterates its concerns on risks associated with this opioid FDA More information...
FDA Investigates Multistate Outbreak of Salmonella Infections Linked to Products Reported to Contain Kratom FDA More information...
Chapter 15 of the draft Preventive Controls for Human Food guidance regarding Supply-Chain requirements FDA More information...
FDA Issues Guidance Documents to help Importers and Food Producers meet FSMA Requirements FDA More information...
